ADVERTORIAL, B. Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION. SA Heart Journal, [S. l.], v. 13, n. 1, p. 42–43, 2017. DOI: 10.24170/13-1-1694. Disponível em: https://www.journals.ac.za/SAHJ/article/view/1694. Acesso em: 8 oct. 2025.